Article
Generation of an isogenic gene-corrected iPSC line (PUMCHi001-A-1) from a familial partial lipodystrophy type 2 (FPLD2) patient with a heterozygous R349W mutation in the LMNA gene.
Stem cell research - 1 Apr 2020
Xiao Cheng, Yu Miao, Liu Jieying, Wu Han, Deng Mingqun, Zhang Qian, Xiao Xinhua
Abstract excerpt
Familial partial lipodystrophy type 2 (FPLD2) is a rare autosomal dominant metabolic disorder caused by heterozygous mutations in the LMNA gene, which encodes for the lamin A/C. Although multiple mutations have been reported in FPLD2 patients, the mechanism remains unclear due to the lack of cellular models for the disease. We previously have generated an iPSC line (PUMCHi001-A) from a FPLD2 patient with a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
